Concepts (287)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Tuberculosis, Pulmonary | 12 | 2018 | 1171 | 3.12 | Why? |
| South Africa | 31 | 2021 | 3326 | 1.61 | Why? |
| Respiratory Sounds | 5 | 2019 | 294 | 1.40 | Why? |
| Isoniazid | 3 | 2018 | 105 | 1.21 | Why? |
| Environmental Exposure | 5 | 2021 | 1558 | 1.18 | Why? |
| Tobacco Smoke Pollution | 2 | 2018 | 181 | 1.13 | Why? |
| Antitubercular Agents | 3 | 2018 | 775 | 1.11 | Why? |
| Tuberculin Test | 4 | 2018 | 141 | 1.01 | Why? |
| Respiratory Tract Infections | 10 | 2019 | 6817 | 0.85 | Why? |
| AIDS-Related Opportunistic Infections | 2 | 2017 | 260 | 0.82 | Why? |
| Pneumonia | 6 | 2020 | 5652 | 0.81 | Why? |
| Sputum | 3 | 2018 | 1720 | 0.80 | Why? |
| Mycobacterium tuberculosis | 4 | 2019 | 1164 | 0.79 | Why? |
| Child Development | 3 | 2019 | 352 | 0.78 | Why? |
| Webcasts as Topic | 1 | 2020 | 118 | 0.74 | Why? |
| Tuberculosis, Lymph Node | 2 | 2017 | 27 | 0.74 | Why? |
| Child Health | 4 | 2021 | 940 | 0.73 | Why? |
| Tuberculosis, Gastrointestinal | 1 | 2017 | 9 | 0.73 | Why? |
| Infant | 31 | 2021 | 30274 | 0.71 | Why? |
| Respiratory Syncytial Virus Infections | 4 | 2021 | 1234 | 0.67 | Why? |
| Metapneumovirus | 2 | 2011 | 465 | 0.65 | Why? |
| Birth Weight | 2 | 2017 | 250 | 0.64 | Why? |
| Ultrasonography | 5 | 2019 | 4409 | 0.62 | Why? |
| Respiration Disorders | 2 | 2020 | 526 | 0.58 | Why? |
| Streptococcus pneumoniae | 2 | 2018 | 827 | 0.57 | Why? |
| Airway Obstruction | 1 | 2017 | 182 | 0.56 | Why? |
| HIV Infections | 12 | 2020 | 11620 | 0.56 | Why? |
| Respiratory Syncytial Virus, Human | 2 | 2021 | 846 | 0.55 | Why? |
| Pulmonary Medicine | 2 | 2020 | 706 | 0.53 | Why? |
| Bronchiectasis | 1 | 2018 | 312 | 0.53 | Why? |
| Antibodies, Bacterial | 1 | 2018 | 510 | 0.53 | Why? |
| Latent Tuberculosis | 1 | 2018 | 324 | 0.52 | Why? |
| Maternal Health | 1 | 2018 | 331 | 0.51 | Why? |
| Child, Preschool | 22 | 2019 | 36283 | 0.50 | Why? |
| Pediatrics | 2 | 2020 | 2969 | 0.49 | Why? |
| Child | 31 | 2021 | 70012 | 0.49 | Why? |
| Community-Acquired Infections | 2 | 2017 | 2328 | 0.46 | Why? |
| Trimethoprim, Sulfamethoxazole Drug Combination | 2 | 2017 | 170 | 0.45 | Why? |
| Dysbiosis | 1 | 2017 | 685 | 0.44 | Why? |
| Capacity Building | 1 | 2017 | 683 | 0.43 | Why? |
| Human bocavirus | 1 | 2011 | 142 | 0.42 | Why? |
| Pneumococcal Infections | 1 | 2017 | 562 | 0.41 | Why? |
| Respiratory Function Tests | 4 | 2019 | 1755 | 0.41 | Why? |
| Pneumonia, Bacterial | 1 | 2017 | 843 | 0.40 | Why? |
| Seasons | 2 | 2021 | 4071 | 0.38 | Why? |
| Thorax | 1 | 2019 | 1873 | 0.38 | Why? |
| Air Pollution, Indoor | 1 | 2018 | 816 | 0.37 | Why? |
| Pneumococcal Vaccines | 3 | 2020 | 571 | 0.37 | Why? |
| Bocavirus | 1 | 2008 | 74 | 0.37 | Why? |
| Fellowships and Scholarships | 1 | 2017 | 931 | 0.36 | Why? |
| Anti-Retroviral Agents | 1 | 2017 | 1099 | 0.36 | Why? |
| Infant, Newborn | 13 | 2021 | 23105 | 0.36 | Why? |
| Adjuvants, Immunologic | 1 | 2018 | 1709 | 0.35 | Why? |
| Asthma | 4 | 2020 | 4383 | 0.35 | Why? |
| BCG Vaccine | 1 | 2018 | 1137 | 0.34 | Why? |
| Tuberculosis | 3 | 2019 | 2895 | 0.33 | Why? |
| Developing Countries | 4 | 2020 | 4283 | 0.32 | Why? |
| Parvoviridae Infections | 1 | 2008 | 222 | 0.31 | Why? |
| Picornaviridae Infections | 1 | 2011 | 544 | 0.30 | Why? |
| Paramyxoviridae Infections | 1 | 2008 | 364 | 0.28 | Why? |
| Coronavirus NL63, Human | 1 | 2011 | 669 | 0.28 | Why? |
| Point-of-Care Systems | 1 | 2018 | 2955 | 0.28 | Why? |
| Prenatal Exposure Delayed Effects | 2 | 2019 | 319 | 0.27 | Why? |
| HIV | 3 | 2019 | 1116 | 0.26 | Why? |
| Global Health | 6 | 2020 | 13911 | 0.26 | Why? |
| Radiography, Thoracic | 3 | 2017 | 5486 | 0.26 | Why? |
| Lung Diseases | 1 | 2017 | 2361 | 0.25 | Why? |
| Medication Adherence | 3 | 2020 | 1270 | 0.25 | Why? |
| Humans | 61 | 2021 | 930598 | 0.24 | Why? |
| Molecular Diagnostic Techniques | 1 | 2018 | 4239 | 0.23 | Why? |
| Intimate Partner Violence | 2 | 2018 | 363 | 0.23 | Why? |
| Risk Factors | 15 | 2021 | 71621 | 0.23 | Why? |
| Pneumonia, Pneumocystis | 1 | 2006 | 322 | 0.23 | Why? |
| Male | 33 | 2021 | 367725 | 0.22 | Why? |
| Female | 35 | 2021 | 380317 | 0.21 | Why? |
| Lung | 4 | 2021 | 31049 | 0.21 | Why? |
| Prospective Studies | 10 | 2019 | 43301 | 0.20 | Why? |
| Longitudinal Studies | 4 | 2021 | 9893 | 0.20 | Why? |
| Mothers | 4 | 2018 | 1624 | 0.20 | Why? |
| Respiratory Syncytial Virus Vaccines | 1 | 2020 | 104 | 0.20 | Why? |
| Poverty | 3 | 2020 | 2302 | 0.20 | Why? |
| Hospitals, Pediatric | 2 | 2021 | 1792 | 0.19 | Why? |
| Chronic Disease | 3 | 2020 | 5139 | 0.19 | Why? |
| Breast Feeding | 3 | 2019 | 1585 | 0.19 | Why? |
| Meconium | 1 | 2018 | 8 | 0.19 | Why? |
| Vaccination | 4 | 2017 | 19050 | 0.19 | Why? |
| Early Diagnosis | 2 | 2018 | 2443 | 0.18 | Why? |
| Environmental Health | 1 | 2021 | 203 | 0.18 | Why? |
| Colony Count, Microbial | 1 | 2018 | 177 | 0.18 | Why? |
| Stress, Psychological | 3 | 2018 | 10231 | 0.18 | Why? |
| Brain Stem | 1 | 2019 | 131 | 0.18 | Why? |
| Mediastinal Diseases | 1 | 2017 | 38 | 0.17 | Why? |
| Pneumonia, Pneumococcal | 1 | 2020 | 251 | 0.17 | Why? |
| Incidence | 6 | 2019 | 25622 | 0.17 | Why? |
| Water Supply | 1 | 2020 | 294 | 0.17 | Why? |
| Delivery of Health Care | 2 | 2020 | 15909 | 0.17 | Why? |
| Growth Disorders | 1 | 2017 | 91 | 0.16 | Why? |
| Research Support as Topic | 1 | 2020 | 327 | 0.16 | Why? |
| Sanitation | 1 | 2020 | 403 | 0.16 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.16 | Why? |
| Vaccines, Conjugate | 1 | 2018 | 328 | 0.15 | Why? |
| Virus Cultivation | 2 | 2011 | 579 | 0.15 | Why? |
| Pregnancy | 8 | 2019 | 23879 | 0.15 | Why? |
| Cerebral Cortex | 1 | 2019 | 276 | 0.15 | Why? |
| Carbon Monoxide | 1 | 2017 | 167 | 0.15 | Why? |
| Antiretroviral Therapy, Highly Active | 2 | 2019 | 952 | 0.15 | Why? |
| Fetal Growth Retardation | 1 | 2017 | 217 | 0.15 | Why? |
| Maternal Exposure | 1 | 2017 | 173 | 0.15 | Why? |
| Mother-Child Relations | 1 | 2017 | 148 | 0.15 | Why? |
| Anti-HIV Agents | 2 | 2019 | 2209 | 0.15 | Why? |
| White Matter | 1 | 2019 | 369 | 0.14 | Why? |
| Africa | 3 | 2021 | 2986 | 0.14 | Why? |
| Regression Analysis | 2 | 2019 | 2484 | 0.14 | Why? |
| Education | 1 | 2020 | 434 | 0.14 | Why? |
| Neurodevelopmental Disorders | 1 | 2019 | 284 | 0.14 | Why? |
| Rotavirus Vaccines | 1 | 2017 | 203 | 0.14 | Why? |
| Prevalence | 5 | 2021 | 25773 | 0.14 | Why? |
| Sequence Analysis, DNA | 2 | 2017 | 2830 | 0.14 | Why? |
| Anti-Infective Agents | 1 | 2006 | 1766 | 0.14 | Why? |
| Rotavirus | 1 | 2017 | 329 | 0.14 | Why? |
| Respiratory Mechanics | 1 | 2019 | 585 | 0.14 | Why? |
| Walk Test | 1 | 2017 | 461 | 0.14 | Why? |
| Ghana | 1 | 2017 | 763 | 0.13 | Why? |
| Crowding | 1 | 2020 | 731 | 0.13 | Why? |
| Kenya | 1 | 2017 | 887 | 0.13 | Why? |
| Nasopharynx | 3 | 2018 | 10224 | 0.13 | Why? |
| Breath Tests | 1 | 2017 | 338 | 0.13 | Why? |
| Linear Models | 2 | 2017 | 1914 | 0.13 | Why? |
| Pneumonia, Viral | 7 | 2021 | 243684 | 0.13 | Why? |
| Cigarette Smoking | 1 | 2017 | 337 | 0.13 | Why? |
| Immunoglobulin G | 1 | 2018 | 21571 | 0.13 | Why? |
| Fetal Blood | 1 | 2017 | 573 | 0.13 | Why? |
| Rotavirus Infections | 1 | 2017 | 355 | 0.13 | Why? |
| Uganda | 1 | 2017 | 1057 | 0.13 | Why? |
| Respiratory Syncytial Viruses | 1 | 2017 | 612 | 0.13 | Why? |
| Cognition Disorders | 1 | 2018 | 574 | 0.12 | Why? |
| Genotype | 2 | 2017 | 4697 | 0.12 | Why? |
| Coronavirus Infections | 7 | 2021 | 253789 | 0.12 | Why? |
| DNA Methylation | 1 | 2017 | 688 | 0.12 | Why? |
| Cognition | 2 | 2019 | 1394 | 0.12 | Why? |
| Tuberculosis, Multidrug-Resistant | 1 | 2017 | 433 | 0.12 | Why? |
| Africa South of the Sahara | 1 | 2017 | 1335 | 0.11 | Why? |
| Adolescent | 7 | 2019 | 86841 | 0.11 | Why? |
| Cats | 1 | 2018 | 1890 | 0.11 | Why? |
| DNA | 1 | 2017 | 778 | 0.11 | Why? |
| Mental Health | 1 | 2018 | 15770 | 0.11 | Why? |
| Cohort Studies | 7 | 2018 | 36005 | 0.10 | Why? |
| Malnutrition | 1 | 2020 | 932 | 0.10 | Why? |
| Program Development | 1 | 2017 | 1089 | 0.10 | Why? |
| Disease Progression | 2 | 2020 | 13580 | 0.10 | Why? |
| Cognitive Dysfunction | 2 | 2019 | 1389 | 0.10 | Why? |
| Models, Statistical | 2 | 2017 | 5312 | 0.10 | Why? |
| Nigeria | 1 | 2017 | 2292 | 0.10 | Why? |
| Self Report | 2 | 2018 | 3802 | 0.10 | Why? |
| Multivariate Analysis | 2 | 2017 | 5440 | 0.10 | Why? |
| Health Education | 1 | 2020 | 1539 | 0.09 | Why? |
| Food Supply | 1 | 2017 | 1027 | 0.09 | Why? |
| Respiratory System | 2 | 2021 | 3213 | 0.09 | Why? |
| Memory, Short-Term | 2 | 2019 | 137 | 0.09 | Why? |
| Sensitivity and Specificity | 2 | 2019 | 22971 | 0.09 | Why? |
| Feces | 2 | 2018 | 4235 | 0.08 | Why? |
| Internationality | 1 | 2020 | 3297 | 0.08 | Why? |
| Sequence Homology | 1 | 2008 | 448 | 0.08 | Why? |
| Pregnancy Complications | 1 | 2017 | 1388 | 0.08 | Why? |
| Alcohol Drinking | 1 | 2017 | 1663 | 0.08 | Why? |
| Perception | 1 | 2017 | 2827 | 0.08 | Why? |
| Diagnostic Tests, Routine | 1 | 2017 | 2643 | 0.08 | Why? |
| Attention | 2 | 2019 | 335 | 0.07 | Why? |
| Environmental Monitoring | 1 | 2018 | 3143 | 0.07 | Why? |
| Occupational Diseases | 1 | 2021 | 2787 | 0.07 | Why? |
| Long-Term Care | 1 | 2017 | 2047 | 0.07 | Why? |
| Influenza Vaccines | 1 | 2021 | 2941 | 0.07 | Why? |
| Case-Control Studies | 2 | 2021 | 17671 | 0.07 | Why? |
| Adult | 12 | 2021 | 244371 | 0.07 | Why? |
| Gastrointestinal Microbiome | 1 | 2018 | 1961 | 0.07 | Why? |
| Pneumocystis carinii | 1 | 2006 | 205 | 0.07 | Why? |
| Occupational Health | 1 | 2020 | 3965 | 0.06 | Why? |
| Pregnant Women | 1 | 2017 | 2535 | 0.06 | Why? |
| Phylogeny | 3 | 2017 | 13341 | 0.06 | Why? |
| Nasal Mucosa | 1 | 2011 | 1218 | 0.06 | Why? |
| Neuropsychological Tests | 2 | 2019 | 954 | 0.06 | Why? |
| Caregivers | 1 | 2018 | 3112 | 0.06 | Why? |
| Schools | 1 | 2018 | 4187 | 0.06 | Why? |
| Cluster Analysis | 1 | 2011 | 3001 | 0.06 | Why? |
| Molecular Sequence Data | 1 | 2008 | 3198 | 0.06 | Why? |
| Molecular Epidemiology | 1 | 2008 | 1638 | 0.06 | Why? |
| Surveys and Questionnaires | 3 | 2018 | 43792 | 0.06 | Why? |
| Influenza, Human | 2 | 2021 | 10779 | 0.06 | Why? |
| Healthcare Disparities | 1 | 2020 | 3893 | 0.06 | Why? |
| Hospitalization | 5 | 2020 | 54280 | 0.06 | Why? |
| Nose | 1 | 2008 | 1093 | 0.06 | Why? |
| Young Adult | 5 | 2021 | 93724 | 0.06 | Why? |
| Biomarkers | 2 | 2018 | 23361 | 0.06 | Why? |
| Hygiene Hypothesis | 1 | 2021 | 56 | 0.05 | Why? |
| Coinfection | 2 | 2018 | 6820 | 0.05 | Why? |
| Infectious Disease Transmission, Vertical | 1 | 2018 | 5164 | 0.05 | Why? |
| Stress Disorders, Post-Traumatic | 1 | 2017 | 2963 | 0.05 | Why? |
| Magnetic Resonance Imaging | 1 | 2017 | 6551 | 0.05 | Why? |
| Fetal Development | 1 | 2021 | 173 | 0.05 | Why? |
| Specimen Handling | 1 | 2017 | 6190 | 0.05 | Why? |
| Oscillometry | 1 | 2019 | 50 | 0.05 | Why? |
| Administration, Oral | 1 | 2006 | 2340 | 0.05 | Why? |
| Proteobacteria | 1 | 2018 | 36 | 0.05 | Why? |
| Coronavirus | 1 | 2008 | 18339 | 0.05 | Why? |
| Diffusion Tensor Imaging | 1 | 2019 | 125 | 0.05 | Why? |
| DNA Contamination | 1 | 2017 | 2 | 0.05 | Why? |
| Firmicutes | 1 | 2018 | 41 | 0.05 | Why? |
| Bifidobacterium | 1 | 2018 | 52 | 0.04 | Why? |
| Psychomotor Performance | 1 | 2019 | 110 | 0.04 | Why? |
| Fever | 1 | 2015 | 7795 | 0.04 | Why? |
| Interatrial Block | 1 | 2017 | 19 | 0.04 | Why? |
| Anatomic Landmarks | 1 | 2017 | 44 | 0.04 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2017 | 10649 | 0.04 | Why? |
| Anthropometry | 1 | 2019 | 233 | 0.04 | Why? |
| Mass Screening | 1 | 2018 | 8005 | 0.04 | Why? |
| Infant Formula | 1 | 2018 | 64 | 0.04 | Why? |
| Infant, Small for Gestational Age | 1 | 2017 | 151 | 0.04 | Why? |
| Viral Load | 1 | 2018 | 15850 | 0.04 | Why? |
| Cross-Sectional Studies | 3 | 2021 | 53120 | 0.04 | Why? |
| Depression | 2 | 2018 | 14116 | 0.04 | Why? |
| Risk Assessment | 1 | 2021 | 25439 | 0.04 | Why? |
| Biostatistics | 1 | 2017 | 116 | 0.04 | Why? |
| Infant, Low Birth Weight | 1 | 2017 | 243 | 0.04 | Why? |
| Odds Ratio | 2 | 2019 | 5861 | 0.04 | Why? |
| CpG Islands | 1 | 2017 | 230 | 0.04 | Why? |
| Oligonucleotide Array Sequence Analysis | 1 | 2017 | 343 | 0.04 | Why? |
| Serogroup | 1 | 2018 | 510 | 0.04 | Why? |
| Polymerase Chain Reaction | 1 | 2011 | 6740 | 0.04 | Why? |
| Disease Transmission, Infectious | 1 | 2019 | 9044 | 0.04 | Why? |
| Data Interpretation, Statistical | 1 | 2000 | 657 | 0.04 | Why? |
| Animals | 2 | 2018 | 78931 | 0.04 | Why? |
| Time Factors | 4 | 2020 | 31397 | 0.04 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.04 | Why? |
| Bacteriological Techniques | 1 | 2017 | 239 | 0.04 | Why? |
| RNA, Ribosomal, 16S | 1 | 2018 | 793 | 0.03 | Why? |
| Mental Disorders | 1 | 2017 | 6742 | 0.03 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.03 | Why? |
| Chi-Square Distribution | 1 | 2017 | 961 | 0.03 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.03 | Why? |
| Pregnancy Complications, Infectious | 1 | 2019 | 11559 | 0.03 | Why? |
| Public Health | 1 | 2019 | 16359 | 0.03 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.03 | Why? |
| United States | 1 | 2020 | 46150 | 0.03 | Why? |
| Language | 1 | 2018 | 655 | 0.03 | Why? |
| Morbidity | 1 | 2019 | 1426 | 0.03 | Why? |
| Appointments and Schedules | 1 | 2020 | 1204 | 0.03 | Why? |
| Bias | 1 | 2017 | 1109 | 0.03 | Why? |
| Neuroimaging | 1 | 2019 | 1106 | 0.03 | Why? |
| Air Pollution | 2 | 2021 | 3504 | 0.03 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.03 | Why? |
| Epigenesis, Genetic | 1 | 2017 | 711 | 0.03 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.03 | Why? |
| Psychometrics | 1 | 2017 | 1269 | 0.02 | Why? |
| Comorbidity | 2 | 2019 | 34796 | 0.02 | Why? |
| Retrospective Studies | 2 | 2019 | 105322 | 0.02 | Why? |
| Socioeconomic Factors | 2 | 2017 | 8495 | 0.02 | Why? |
| Pain Management | 1 | 2018 | 854 | 0.02 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2016 | 1439 | 0.02 | Why? |
| Hospitals | 1 | 2008 | 11793 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.02 | Why? |
| RNA, Viral | 2 | 2017 | 32276 | 0.02 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 13720 | 0.02 | Why? |
| Disease Susceptibility | 1 | 2021 | 4002 | 0.02 | Why? |
| Carrier State | 1 | 2018 | 2100 | 0.02 | Why? |
| Risk | 1 | 2019 | 5288 | 0.02 | Why? |
| Employment | 1 | 2017 | 1754 | 0.02 | Why? |
| Feeding Behavior | 1 | 2018 | 1909 | 0.02 | Why? |
| Diarrhea | 1 | 2017 | 2743 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.02 | Why? |
| Immunization Programs | 1 | 2017 | 2006 | 0.02 | Why? |
| Europe | 1 | 2021 | 12702 | 0.02 | Why? |
| Serologic Tests | 1 | 2018 | 4359 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2019 | 9537 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.02 | Why? |
| Immunity, Innate | 1 | 2021 | 6570 | 0.02 | Why? |
| Computer Simulation | 1 | 2017 | 4982 | 0.01 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2019 | 17020 | 0.01 | Why? |
| Age Factors | 1 | 2021 | 21039 | 0.01 | Why? |
| Treatment Outcome | 1 | 2006 | 51732 | 0.01 | Why? |
| Adaptation, Psychological | 1 | 2017 | 4996 | 0.01 | Why? |
| Hospital Mortality | 1 | 2017 | 22087 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| Telemedicine | 1 | 2020 | 25032 | 0.01 | Why? |
| Aged | 1 | 2021 | 215776 | 0.00 | Why? |
| Middle Aged | 1 | 2021 | 270681 | 0.00 | Why? |